D. O'Toole - 10 Jan 2022 Form 4 Insider Report for OPIANT PHARMACEUTICALS, INC. (OPNT)

Role
Chief Financial Officer
Signature
/s/ David D. O'Toole
Issuer symbol
OPNT
Transactions as of
10 Jan 2022
Transactions value $
-$13,219
Form type
4
Filing time
12 Jan 2022, 15:39:03 UTC
Previous filing
05 Jan 2022
Next filing
29 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OPNT Common Stock Sale -$13.2K -432 -1.2% $30.60 35.6K 10 Jan 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
F2 This transaction was executed in multiple trades at prices ranging from $29.03 to $30.76. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.